Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1988-06-02
1990-06-05
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 24, 536 26, A61K 3152, C07H 1916
Patent
active
049314319
ABSTRACT:
The complex mixture of substances in the product made from human placentae according to the procedure described in U.S. Pat. Nos. 3,526,697 and 4,335,040 includes hypoxanthine. Hypoxanthine is effective in treating arthritis, particularly if administered intradermally at low (e.g., not more than about 0.1 mg. of hypoxanthine per does) dose. Preferably, the dose level is not more than about 0.00002 mg. active material per dose, e.g., 0.1 cc of a dilution not stronger than about 1 mg. of active material per 5,000 ml of diluent.
REFERENCES:
patent: 3526697 (1970-09-01), Livingston
patent: 4081534 (1978-03-01), Elion et al.
patent: 4309419 (1982-01-01), Wolberg et al.
patent: 4322411 (1982-03-01), Vinegar et al.
Carson et al., Proc. Natl. Acad. Sci. (U.S.A.), 79(12), 3848-52, (1982).
Glazer, Robert I., Cancer Chemotherapy, Pharmacol., 4, 227-235 (1980).
Ratech, Howard et al., (1982), Cellular Immunology, 244-251.
Kunz Gary L.
Rollins John W.
LandOfFree
Arthritis treatment with hypoxanthine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arthritis treatment with hypoxanthine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arthritis treatment with hypoxanthine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-491639